Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» melanoma
melanoma
Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.
TheStreet.com
Mon, 06/3/13 - 10:20 am
nivolumab
Merck
melanoma
lambrolizumab
Bristol-Myers Squibb
ASCO
Merck Rushes Forward In Race To Market Cell Death Cancer Drugs
Forbes
Sun, 06/2/13 - 11:56 am
Merck
lambrolizumab
melanoma
Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
The Street
Sun, 06/2/13 - 11:54 am
Merck
labrolizumab
melanoma
New Approvals Spark a Melanoma Drug Battle
Motley Fool
Sat, 06/1/13 - 12:48 pm
melanoma
GSK
Tafinlar
Mekinist
Roche
Bristol-Myers Squibb
3 FDA Stories You Missed This Week
Motley Fool
Sat, 06/1/13 - 12:46 pm
Merck
suvorexant
insomnia
sleep aid
hypnotics
Celgene
Abraxane
prostate cancer
Glaxo
Tafinlar
dabrafenib
melanoma
ASCO '13: Array Drug First to be Effective Against Melanoma of the Eye
The Street
Sat, 06/1/13 - 12:44 pm
Array Biopharma
melanoma
ocular melanoma
selumetinib
AstraZeneca
Bristol drug shrinks melanoma in 31 pct of trial patients
Reuters
Sat, 06/1/13 - 12:24 pm
nivolumab
Bristol-Myers Squibb
melanoma
Amgen melanoma drug improved survival by 21 pct in interim look
Reuters
Sat, 06/1/13 - 12:12 pm
Amgen
T-Vec
Talimogene Laherparepvec
melanoma
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Fierce Biotech
Wed, 05/29/13 - 04:49 pm
FDA
GSK
melanoma
dabrafenib
trametinib
Promising Data on ONCY's Reolysin
Yahoo/Zacks
Sat, 05/25/13 - 11:51 am
Oncolytics
Reolysin
melanoma
metastatic melanoma
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Seeking Alpha
Mon, 05/20/13 - 05:26 pm
Bristol-Myers Squibb
Merck
nivolumab
lambrolizumab
Roche
PD-L1
melanoma
cancer
lung cancer
[video]Will Amgen's Novel Drug Revolutionize Cancer Treatment?
Motley Fool
Mon, 05/20/13 - 05:19 pm
Amgen
Talimogene Laherparepvec
melanoma
Roche immunotherapy shows response over range of cancers
Reuters
Thu, 05/16/13 - 10:22 am
Roche
immunotherapy
MPDL3280A
melanoma
lung cancer
kidney cancer
Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
Bloomberg
Thu, 05/16/13 - 08:49 am
melanoma
Bristol-Myers Squibb
nivolumab
Yervoy
Bristol-Myers Sues Genentech Over ‘Cabilly’ Patents
Bloomberg
Wed, 05/8/13 - 09:08 am
Genentech
Bristol-Myers Squibb
patents
Cabilly
melanoma
colon cancer
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial
Seeking Alpha
Fri, 05/3/13 - 12:57 pm
Vical
Amgen
Bristol-Myers Squibb
OncoSec
ImmunoCellular Therapeutics
Roche
NCT00395070
melanoma
Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Yahoo/AP
Wed, 04/24/13 - 09:34 am
Merck
lambrolizumab
FDA
MK-3475
melanoma
Melanoma: Battle Of 3 Cancer Vaccines
Seeking Alpha
Tue, 04/23/13 - 03:31 pm
melanoma
vaccines
Amgen
Celldex
Oncothyreon
OncoSec
Vical
Array's Up-Coming Value Enhancing Catalysts
Seeking Alpha
Wed, 04/17/13 - 10:50 am
Array Biopharma
Amgen
Novartis
AstraZeneca
selumetinib
MEK162
melanoma
non-small cell lung cancer
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
next ›
last »